Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05098704Phase 2/3Recruiting
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
SclerodermaSystemic Sclerosis
PrincipalinvestigatorStart date: 2022-06-22

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University Hospital, Bordeaux

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Linda WITTKOP, MD

University of Bordeaux

Moderately Similar
1 trials

Shared therapeutic areas:

Raynaud PhenomenonSclerodermaScleroderma, Systemic

Worked with same sponsors:

Ministry for Health and Solidarity, FranceUniversity Hospital, Bordeaux
Collaborated on 1 trial
Similarity Score34%

Marie-Elise TRUCHETET, MD, PhD

University Hospital, Bordeaux

Related
4 trials

Shared therapeutic areas:

Scleroderma, SystemicScleroderma

Worked with same sponsors:

University Hospital, Bordeaux
Similarity Score20%

Keith Sullivan, MD

Duke University

Related
4 trials

Shared therapeutic areas:

SclerodermaScleroderma, Systemic
Similarity Score20%

Steven Kesten, MD

Cytori Therapeutics

Related
4 trials

Shared therapeutic areas:

SclerodermaScleroderma, Systemic
Similarity Score20%

David Launay, MD,PhD

University Hospital, Lille

Related
9 trials

Shared therapeutic areas:

Scleroderma, SystemicScleroderma
Similarity Score20%

Ruixuan Zhu, MD

Second Xiangya Hospital

Related
1 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score10%

Qiubai Li, Professor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
7 trials

Shared therapeutic areas:

Scleroderma
Similarity Score10%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score10%

Dieter Manstein, MD, PhD

Massachusetts General Hospital

Related
7 trials

Shared therapeutic areas:

Scleroderma
Similarity Score10%

Deran Oskay, Prof

Gazi University

Related
6 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05098704Phase 2/3PrincipalInvestigator

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

SclerodermaSystemic Sclerosis
Recruiting

All 1 trials loaded